Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers

Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers

10.3390/cancers13205147

Saved in:

書目詳細資料
Main Authors:	Li, Boheng, Wan, Qin, Li, Zhubo, Chng, Wee-Joo
其他作者:	DEAN'S OFFICE (MEDICINE)
格式:	Review
語言:	English
出版:	MDPI 2022
主題:	Science & Technology Life Sciences & Biomedicine Oncology <p>JAK/STAT</p> lymphoma myeloma inhibitor B-CELL LYMPHOMA CLASSICAL HODGKIN LYMPHOMA JAK-STAT PATHWAY MULTIPLE-MYELOMA CELLS IN-VITRO KAPPA-B ANTITUMOR-ACTIVITY JAK/STAT PATHWAY GENE-REGULATION PHASE-I
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/228997
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
由: Jung Y.Y., et al.
出版: (2019)

Leptin as a neuroprotective agent
由: Tang, B.L.
出版: (2011)

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
由: Iwanski, G.B., et al.
出版: (2015)

Upregulation of the JAK-STAT pathway promotes maturation of human embryonic stem cell-derived cardiomyocytes
由: Ho, Beatrice Xuan, et al.
出版: (2022)

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
由: Song, Tammy Linlin, et al.
出版: (2021)

Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia
由: Ikezoe, T., et al.
出版: (2016)

ROLE OF NOTCH AND JAK/STAT SIGNALING PATHWAYS IN ACUTE MEGAKARYOBLASTIC LEUKEMIA
由: KELLY ONG OOI KEE
出版: (2015)

IDENTIFICATION OF MOLECULAR TARGETS OF TRIS DBA [TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0)]
由: LOUKIK ARORA
出版: (2020)

GRAM DOMAIN-CONTAINING PROTEIN 1B (GRAMD1B) AS A NOVEL REGULATOR OF JAK/STAT SIGNALING MEDIATED TUMORIGENESIS
由: PUJA KHANNA
出版: (2018)

Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
由: Li, F., et al.
出版: (2011)

Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
由: Subramaniam, A., et al.
出版: (2014)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
由: Rajendran, P., et al.
出版: (2014)

Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
由: Kannaiyan, R., et al.
出版: (2014)

Potential of zerumbone as an anti-cancer agent
由: Girisa, S., et al.
出版: (2021)

THE ROLE OF AUTOCRINE HUMAN GROWTH HORMONE IN HUMAN MAMMARY CARCINOMA CELL BEHAVIOR
由: KARMALJEET KAUR KAULSAY
出版: (2019)

Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma
由: Jen, W.-Y., et al.
出版: (2021)

IDENTIFICATION AND CHARACTERIZATION OF NOVEL LONG NON-CODING RNAs IN ACUTE MYELOID LEUKEMIA
由: SRISHTI MISHRA
出版: (2023)

The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies
由: Arora, L, et al.
出版: (2020)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
由: Yang, M.H., et al.
出版: (2021)

Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
由: Ng, Siok-Bian, et al.
出版: (2021)

Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
由: Lee M., et al.
出版: (2020)

IDENTIFICATION OF A NOVEL AGENT THAT CAN SUPPRESS PROLIFERATION, INDUCE APOPTOSIS AND OVERCOME CHEMORESISTANCE IN MULTIPLE MYELOMA
由: RADHAMANI KANNAIYAN
出版: (2014)

NF-?B-MEDIATED INTEGRIN ?3 EXPRESSION LEADS TO INCREASED LAMELLIPODIA FORMATION AND STAT3 ACTIVITY IN p53-DEPLETED CELLS
由: GUO KUNYAO, ALVIN
出版: (2014)

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
由: Kim, S.J., et al.
出版: (2016)

Immunoglobulin m paraproteinaemias
由: Girard, L.-P., et al.
出版: (2021)

Changing patterns of Hodgkin lymphoma incidence in Singapore
由: Hjalgrim, H., et al.
出版: (2014)

Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore
由: Ng, SB, et al.
出版: (2021)

EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implications
由: Li, B., et al.
出版: (2021)

Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL
由: Lim, Shen Kiat, et al.
出版: (2023)

Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.
由: Zhou, Ting, et al.
出版: (2024)

Plasma Factors for the Differentiation of Hodgkin's Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission.
由: Zeng, Qun, et al.
出版: (2023)

Defining Essential Enhancers for Pluripotent Stem Cells Using a Features-Oriented CRISPR-Cas9 Screen
由: Wang, H.F., et al.
出版: (2021)

Non-Hodgkin's lymphoma in an Asian population: 1968-1992 time trends and ethnic differences in Singapore
由: Seow, A., et al.
出版: (2014)

INTERACTIONS BETWEEN HEPACAM AND CD137 IN HODGKIN REED-STERNBERG CELLS ENHANCE LEUKOCYTES RECRUITMENT
由: SEAH MEI YING, JESSICA
出版: (2017)

Factor models for asset returns based on transformed factors
由: Li, J, et al.
出版: (2019)

Relationship of JAK2 (V617F) allelic burden with clinico-haematological manifestations of philadelphia-negative myeloproliferative neoplasms
由: Yow, K.S., et al.
出版: (2021)

Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma
由: Thoennissen, N.H., et al.
出版: (2016)

Epstein–Barr virus-encoded LMP1 induces ectopic CD137 expression on Hodgkin and Reed–Sternberg cells via the PI3K-AKT-mTOR pathway
由: SNEHA PRIYA ARAVINTH, et al.
出版: (2019)

DESIGN AND SYNTHESIS OF DUAL INHIBITORS OF JANUS KINASE AND HISTONE DEACETYLASE
由: CHU YU-YI
出版: (2019)

Doubly Robust Regression Analysis for Data Fusion
由: Evans, Katherine, et al.
出版: (2020)